Analysis: Still wary of Russian vaccine, Brazil clears its own 'study' for more data

BRASILIA (Reuters) - Russian vaccine developers cheered hard-won access to Brazil's market last week, but with less than a million doses cleared for import, public health experts say the approval is more like a late-stage trial for the Sputnik V shot. Read full story
http://dlvr.it/S1RYvn